{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:43:34Z","timestamp":1777319014425,"version":"3.51.4"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In chronic kidney disease (CKD), phosphate homoeostasis plays a central role in the development of mineral and bone disorder (MBD) together with decreased serum calcium and elevated serum parathyroid hormone, fibroblast growth factor 23 and sclerostin levels. Today there are only a few data exploring the direct role of abnormal phosphate homoeostasis and hyperphosphataemia in the development of CKD-MBD. On the other hand, several studies have looked at the link between hyperphosphataemia and cardiovascular morbidity and mortality in CKD, but there is a lack of evidence to indicate that lowering phosphate levels improves cardiovascular outcomes in this population. Furthermore, the impact of liberalizing phosphate targets on CKD-MBD progression and bone fracture is currently not known. In this review we discuss the central role of phosphate in the pathogenesis of CKD-MBD and how it may be associated with fracture risk, both in hyper- and hypophosphataemia.<\/jats:p>","DOI":"10.1093\/ndt\/gfz196","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T19:27:47Z","timestamp":1567625267000},"page":"405-412","source":"Crossref","is-referenced-by-count":22,"title":["Phosphate and bone fracture risk in chronic kidney disease patients"],"prefix":"10.1093","volume":"36","author":[{"given":"Maria","family":"Fusaro","sequence":"first","affiliation":[{"name":"National Research Council, Institute of Clinical Physiology, Pisa, Italy"},{"name":"Department of Medicine, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Holden","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charmaine","family":"Lok","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[{"name":"National Research Council, Institute of Clinical Physiology, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Laboratory Medicine Unit, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Aghi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Clinica Medica 1, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-2160","authenticated-orcid":false,"given":"Maurizio","family":"Gallieni","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences \u2018L. Sacco\u2019, Nephrology and Dialysis Unit, ASST Fatebenefratelli-Sacco, Universit\u00e0 di Milano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-6252","authenticated-orcid":false,"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, ASST Santi Paolo and Carlo, University of Milan and Renal Division, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"2021022209000639600_gfz196-B1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2021022209000639600_gfz196-B2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ndt\/gft352","article-title":"Increased bone fractures among elderly United States hemodialysis patients","volume":"29","author":"Wagner","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2021022209000639600_gfz196-B3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1525-139X.2007.00309.x","article-title":"Phosphorus homeostasis in normal health and chronic kidney disease patients with special emphasis on dietary phosphorus intake","volume":"20","author":"Uribarri","year":"2007","journal-title":"Semin Dial"},{"key":"2021022209000639600_gfz196-B5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1986.252","article-title":"The absorption of dietary phosphorus and calcium in hemodialysis patients","volume":"30","author":"Ramirez","year":"1986","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/ndt\/gfv055","article-title":"The challenge of controlling phosphorus in chronic kidney disease","volume":"31","author":"Cannata-And\u00eda","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2021022209000639600_gfz196-B7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000468915","article-title":"Phosphate in chronic kidney disease progression","volume":"190","author":"Cozzolino","year":"2017","journal-title":"Contrib Nephrol"},{"key":"2021022209000639600_gfz196-B8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk of mortality","volume":"84","author":"Cannata-Andia","year":"2013","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2021022209000639600_gfz196-B11","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease\u2013mineral bone disorder (CKD-MBD) really a syndrome?","volume":"29","author":"Cozzolino","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2021022209000639600_gfz196-B12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrneph.2015.153","article-title":"Phosphate and FGF-23 homeostasis after kidney transplantation","volume":"11","author":"Baia","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2021022209000639600_gfz196-B13","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","article-title":"The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling","volume":"63","author":"Rojas","year":"2003","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2021022209000639600_gfz196-B15","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00467-012-2175-z","article-title":"Phosphate homeostasis and its role in bone health","volume":"27","author":"Penido","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2021022209000639600_gfz196-B16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ajkd.2007.08.019","article-title":"Increased risk of hip fracture among men with CKD","volume":"51","author":"Dooley","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2021022209000639600_gfz196-B18","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"2021022209000639600_gfz196-B20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","article-title":"Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis","volume":"18","author":"Spasovski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2021022209000639600_gfz196-B21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2021022209000639600_gfz196-B22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2021022209000639600_gfz196-B23","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Ure\u00f1a","year":"1999","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2215\/CJN.09950818","article-title":"Changes in bone histomorphometry after kidney transplantation","volume":"14","author":"Keronen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B25","first-page":"1133","article-title":"Inorganic phosphate induces apoptosis of osteoblast-like cells in culture","volume":"102","author":"Meleti","year":"2000","journal-title":"Bone"},{"key":"2021022209000639600_gfz196-B26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcp.10270","article-title":"Effect of a high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity","volume":"196","author":"Kanatani","year":"2003","journal-title":"J Cell Physiol"},{"key":"2021022209000639600_gfz196-B27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11914-011-0053-4","article-title":"FGF23 in skeletal modeling and remodeling","volume":"9","author":"Lu","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"2021022209000639600_gfz196-B29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jbmr.3094","article-title":"Serum phosphate is associated with fracture risk: the Rotterdam study and MrOS","volume":"32","author":"Campos-Obando","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2021022209000639600_gfz196-B30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11914-017-0398-4","article-title":"Effects of excessive dietary phosphorus intake on bone health","volume":"15","author":"Vorland","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"2021022209000639600_gfz196-B31","doi-asserted-by":"crossref","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","article-title":"Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease \u2013 role of sclerostin?","volume":"8","author":"Ferreira","year":"2013","journal-title":"PLoS One"},{"key":"2021022209000639600_gfz196-B32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ki.2014.372","article-title":"Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease","volume":"87","author":"de Oliveira","year":"2015","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dicckkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B35","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/01.ASN.0000133022.32912.95","article-title":"Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?","volume":"15","author":"Behets","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B36","first-page":"284","article-title":"Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years","volume":"70","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"2021022209000639600_gfz196-B37","doi-asserted-by":"crossref","first-page":"e8664","DOI":"10.1097\/MD.0000000000008664","article-title":"Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated by adynamic bone disease","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2021022209000639600_gfz196-B38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2021022209000639600_gfz196-B39","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1210\/en.2008-0205","article-title":"Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats","volume":"149","author":"Sampath","year":"2008","journal-title":"Endocrinology"},{"key":"2021022209000639600_gfz196-B40","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"2021022209000639600_gfz196-B42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD\u2013diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B43","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"2021022209000639600_gfz196-B45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00223-013-9722-x","article-title":"High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications","volume":"93","author":"Fusaro","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"2021022209000639600_gfz196-B46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF03337737","article-title":"Prevalence of vertebral fracture in postmenopausal women with lumbar osteopenia using MorphoXpress\u00ae (OSTEOXPRESS Study)","volume":"22","author":"Arboleya","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"2021022209000639600_gfz196-B47","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1359\/jbmr.091025","article-title":"Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency","volume":"25","author":"Giannini","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2021022209000639600_gfz196-B48","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2021022209000639600_gfz196-B49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.13363","article-title":"Serum phosphorus levels and fracture following renal transplantation","volume":"87","author":"Aleksova","year":"2017","journal-title":"Clin Endocrinol"},{"key":"2021022209000639600_gfz196-B50","first-page":"111","article-title":"The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"32","author":"Habbous","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2021022209000639600_gfz196-B51","doi-asserted-by":"crossref","first-page":"579434","DOI":"10.1155\/2015\/579434","article-title":"A study to inform the design of a national multicenter randomized controlled trial to evaluate if reducing serum phosphate to normal levels improves clinical outcomes including mortality, cardiovascular events, bone pain, or fracture in patients on dialysis","volume":"2015","author":"Bhargava","year":"2015","journal-title":"Int J Nephrol"},{"key":"2021022209000639600_gfz196-B52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12882-019-1216-2","article-title":"A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis","volume":"20","author":"Bhargava","year":"2019","journal-title":"BMC Nephrol"},{"key":"2021022209000639600_gfz196-B53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2215\/CJN.10941016","article-title":"Two phosphAte taRGets in end-stage renal disease trial (TARGET): a randomized controlled trial","volume":"12","author":"Wald","year":"2017","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/3\/405\/36327607\/gfz196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/3\/405\/36327607\/gfz196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T23:44:20Z","timestamp":1721691860000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/36\/3\/405\/5588742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10,17]]},"published-print":{"date-parts":[[2021,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz196","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2019,10,17]]}}}